Producing and using timely comparative evidence on drugs: lessons from clinical trials for covid-19
bmj, 2020•bmj.com
… However, the large volume of studies may paradoxically limit the generation of robust
evidence and complicate the formulation of trustworthy guidance and decisions related to
drug use if the current research is duplicative and redundant or produces conflicting data.Indeed,
the multiplicity of … We outline five priorities for greater collaboration and coordination
among trialists, meta-analysts, guideline developers, and other stakeholders to facilitate
producing and using trustworthy comparative evidence and guidance (table 1). These are …
evidence and complicate the formulation of trustworthy guidance and decisions related to
drug use if the current research is duplicative and redundant or produces conflicting data.Indeed,
the multiplicity of … We outline five priorities for greater collaboration and coordination
among trialists, meta-analysts, guideline developers, and other stakeholders to facilitate
producing and using trustworthy comparative evidence and guidance (table 1). These are …
Huseyin Naci and colleagues call for greater collaboration among trialists, meta-analysts, and guidance developers to improve the evidence base for new treatments
bmj.com
以上显示的是最相近的搜索结果。 查看全部搜索结果